Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,707.00
Bid: 1,705.00
Ask: 1,707.00
Change: -10.00 (-0.58%)
Spread: 2.00 (0.117%)
Open: 1,738.00
High: 1,738.00
Low: 1,688.00
Prev. Close: 1,717.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal Update

10 Jul 2017 13:30

RNS Number : 5692K
Smiths Group PLC
10 July 2017
 

 

News Release

London, 10 July 2017

For immediate release

 

Smiths Group completes divestment ofMorpho Detection's former trace business

Smiths Group plc ("Smiths Group") today announces that it has completed the sale of the explosive trace detection business formerly owned by Morpho Detection (the "Trace Business") to OSI Systems, Inc. for an enterprise value of $75.5 million, subject to customary working capital adjustments. The proceeds will be reinvested in attractive growth opportunities.

As previously announced, in connection with its acquisition of Morpho Detection from Safran, Smiths Group had made commitments to the European Commission and the Department of Justice to sell the Trace Business.

 

ENDS

 

Investor enquiries

Jemma Spalton, Smiths Group

+44 (0)20 7004 1637

+44 (0)78 6739 0350

jemma.spalton@smiths.com 

 

Marion Le Bot, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

marion.lebot@smiths.com 

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

Deborah Scott, FTI Consulting

+44 (0)203 727 1459

+44 (0)797 953 7449

smiths@fticonsulting.com

 

 

Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Smiths Group employs more than 22,000 people in over 50 countries. For more information visit www.smiths.com.

 

 

Disclaimer

This announcement contains certain statements that are forward-looking statements. They appear in a number of places throughout this announcement and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and, unless otherwise required by applicable law, Smiths undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast.

 

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per Smiths ordinary share for the current or future financial years would necessarily match or exceed the historical published earnings per Smiths ordinary share. Prices and values of, and income from, shares may go down as well as up and an investor may not get back the amount invested. It should be noted that past performance is no guide to future performance. Persons needing advice should consult an independent financial adviser.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURSWRBOABARR
Date   Source Headline
4th Jan 20214:08 pmRNSTotal Voting Rights
23rd Dec 20201:24 pmRNSHolding(s) in Company - Replacement
16th Dec 20205:17 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
19th Nov 20209:03 amRNSDirectorate Change
16th Nov 20204:30 pmRNSResult of AGM
16th Nov 20207:00 amRNSSmiths Group Q1 Trading Statement
4th Nov 20204:41 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:36 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:01 amRNSBlock listing Interim Review
2nd Nov 202010:00 amRNSTotal Voting Rights
28th Oct 20204:09 pmRNSDirector/PDMR Shareholding
16th Oct 20205:46 pmRNSDirector/PDMR Shareholding
15th Oct 20205:41 pmRNSDirector/PDMR Shareholding
15th Oct 20208:00 amRNSAnnual Financial Report
1st Oct 202011:00 amRNSTotal Voting Rights
24th Sep 20207:15 amRNSDirectorate Change
24th Sep 20207:00 amRNSSmiths Group plc FY2020 Annual Results
1st Sep 202011:00 amRNSTotal Voting Rights
6th Aug 20202:06 pmRNSDirector/PDMR Shareholding
3rd Aug 20201:06 pmRNSDirector/PDMR Shareholding
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20207:00 amRNSTrading update & strategic restructuring
22nd Jun 20209:33 amRNSAdditional Listing
20th May 20209:30 amRNSDirector/PDMR Shareholding
1st May 202011:00 amRNSBlock listing Interim Review
1st May 202010:45 amRNSDirector/PDMR Shareholding
30th Apr 20205:15 pmRNSTotal Voting Rights
30th Apr 20202:30 pmRNSDirector/PDMR Shareholding
27th Apr 20202:56 pmRNSDoc re. Listing Rule 9.2.6E
16th Apr 20204:15 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSInterim Results
31st Mar 20207:00 amRNSTrading Update
27th Mar 20203:47 pmRNSFCA moratorium on publication of results
3rd Feb 20203:57 pmRNSDirector/PDMR Shareholding
31st Jan 20205:00 pmRNSTotal Voting Rights
8th Jan 20204:38 pmRNSDirectorate Change
2nd Jan 20202:30 pmRNSTotal Voting Rights
2nd Dec 20199:00 amRNSTotal Voting Rights
13th Nov 201912:57 pmRNSResult of AGM
13th Nov 20197:00 amRNSSmiths Group FY2020 Q1 Trading Statement
11th Nov 201910:57 amRNSDirector/PDMR Shareholding
4th Nov 20194:45 pmRNSBlock listing Interim Review
1st Nov 201910:30 amRNSDirector/PDMR Shareholding
1st Nov 201910:30 amRNSTotal Voting Rights
11th Oct 20198:00 amRNSAnnual Financial Report
9th Oct 20192:52 pmRNSDirector/PDMR Shareholding
7th Oct 20194:08 pmRNSDirector/PDMR Shareholding
30th Sep 20195:56 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.